1.Zouhiri F, Mouscadet JF, Mekouar K, Desmaële D, Savouré D, Leh H, Subra F, Le Bret M, Auclair C, d'Angelo J.. (2000) Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture., 43 (8):[PMID:10780910][10.1021/jm990467o]
2.Polanski J, Zouhiri F, Jeanson L, Desmaële D, d'Angelo J, Mouscadet JF, Gieleciak R, Gasteiger J, Le Bret M.. (2002) Use of the Kohonen neural network for rapid screening of ex vivo anti-HIV activity of styrylquinolines., 45 (21):[PMID:12361391][10.1021/jm020845g]
3.Prado-Prado FJ, Martinez de la Vega O, Uriarte E, Ubeira FM, Chou KC, González-Díaz H.. (2009) Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks., 17 (2):[PMID:19112024][10.1016/j.bmc.2008.11.075]
4.Sliman F, Blairvacq M, Durieu E, Meijer L, Rodrigo J, Desmaële D.. (2010) Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase., 20 (9):[PMID:20363627][10.1016/j.bmcl.2010.03.061]
5.Leonard JT, Roy K.. (2008) Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors., 43 (1):[PMID:17452064][10.1016/j.ejmech.2007.02.021]